AKAM vs CELUW · P/E 27, rev $2.17B vs rev $54.2M
Akamai Technologies Inc (AKAM) versus Celularity Inc (CELUW) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Celularity Inc (CELUW) common stock listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. CELUW currently screens at market cap $0.
Not investment advice. Open the AKAM and CELUW stock pages for the full models.
Not investment advice.